Instead of asking questions that no one can answer as they are not working directly on the project why don't you ask the company secretary?
OCC Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
I88 History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
